Zou et al. studied the ACE inhibitor enalapril and found a significant reduction in SBP of −12.6 ± 15.9 mmHg and DBP of −8.9 ± 6.5 mmHg in OSA patients with HT [54]. This evidence concerns the gene ACE and hematocrit.